These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37800781)

  • 21. Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.
    Sansone G; Bonifati DM
    J Neurol; 2022 Aug; 269(8):3965-3981. PubMed ID: 35503373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
    Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
    Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
    Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
    Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia gravis following human papillomavirus vaccination: a case report.
    Chung JY; Lee SJ; Shin BS; Kang HG
    BMC Neurol; 2018 Dec; 18(1):222. PubMed ID: 30593270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves.
    Doron A; Piura Y; Vigiser I; Kolb H; Regev K; Nesher N; Karni A
    J Neurol; 2022 Dec; 269(12):6193-6201. PubMed ID: 35907046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine.
    Abicic A; Sitas B; Adamec I; Bilic E; Habek M
    Cureus; 2022 Jul; 14(7):e27213. PubMed ID: 36035038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis.
    Chavez A; Pougnier C
    J Prim Care Community Health; 2021; 12():21501327211051933. PubMed ID: 34709075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis.
    Ahmed SK; Mohamed MG; Essa RA; Ahmed Rashad EA; Ibrahim PK; Khdir AA; Wsu ZH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102513. PubMed ID: 35660931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular motility disorders following coronavirus disease-19 vaccination.
    Park KA; Jeon H; Choi DG; Jung JH; Shin HJ; Lee BJ; Moon Y; Lee SY; Lee DC; Cho SY; Kim SJ; Oh SY; Moon S; Oh SY; Choi DD; Choi MY; Kim WJ; Kim US; Lee HJ; Kim Y
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1127-1139. PubMed ID: 36383278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study.
    Li HY; Shao LY; Song M; Hu SM; Yue YX; Li HF
    Front Immunol; 2022; 13():923017. PubMed ID: 35990671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to letter to the editor regarding
    Maher DI; Hogarty D; Ben Artsi E
    Orbit; 2022 Oct; 41(5):662-663. PubMed ID: 35686598
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.
    Formeister EJ; Wu MJ; Chari DA; Meek R; Rauch SD; Remenschneider AK; Quesnel AM; de Venecia R; Lee DJ; Chien W; Stewart CM; Galaiya D; Kozin ED; Sun DQ
    JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):307-315. PubMed ID: 35201274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis.
    Chou OHI; Mui J; Chung CT; Radford D; Ranjithkumar S; Evbayekha E; Nam R; Pay L; Satti DI; Garcia-Zamora S; Bazoukis G; Çinier G; Lee S; Vassiliou VS; Liu T; Tse G; Wong ICK; ; Chou OHI; Liu T; Tse G
    Clin Res Cardiol; 2022 Oct; 111(10):1161-1173. PubMed ID: 35906423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis.
    Reyes-Leiva D; López-Contreras J; Moga E; Pla-Juncà F; Lynton-Pons E; Rojas-Garcia R; Turon-Sans J; Querol L; Olive M; Álvarez-Velasco R; Caballero-Ávila M; Carbayo Á; Vesperinas-Castro A; Domingo P; Illa I; Gallardo E; Cortés-Vicente E
    Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35728947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
    Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
    Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.